Therapeutic treatment
US7932263B2 · kind B2 · utility
1Cited by
17References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 22, 2004 |
| Grant date | Apr 26, 2011 |
| Priority date | — |
| Expiry date | Mar 8, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A combination comprising candesartan and rosuvastatin for the prevention or treatment of arteriosclerosis and for the prevention of cardiovascular events is described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.